ミズーリ州における転移性癌の臨床試験
ミズーリ州内の拠点で、転移性癌に関する59件の研究が参加者を募集しています。
ミズーリ州内の都市
公式研究テキスト（英語）
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Saint Francis Medical Center, Cape Girardeau
- Saint Luke's Hospital, Chesterfield
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- 他13件
被験者募集中第2相
全年齢 · 全性別 · 2026/10/02更新 · NCT05564377A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Washington University School of Medicine in St. Louis, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06465069Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Missouri Cancer Associates, Columbia
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07562152Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
- Washington University School of Medicine, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT05372614A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Washington University Medicine, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06270706A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
- Washington University School of Medicine, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06234605Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell Carcinoma
- Washington University in St. Louis, St Louis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT05287945Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- St. Lukes Hospital of Kansas City, Kansas City
- Washington University School of Medicine, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06625775A Study of ASP3082 in Adults With Advanced Solid Tumors
- Washington University School of Medicine, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/30更新 · NCT05382559Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Siteman Cancer Center, St Louis
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT06943755A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Washington University School of Medicine in St. Louis, St Louis
被験者募集中第1/2相
25歳以下 · 全性別 · 2026/09/25更新 · NCT04094610A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Premier Imaging, Kansas City
- St. Joseph Medical Center, Kansas City
- MidAmerica Cancer Care - American Oncology Partners, Kansas City
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06989437A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, St Louis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06103864ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- Washington University School of Medicine- Siteman Cancer Center, St Louis
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07007559A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
- Washington University School of Medicine, St Louis
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/09/24更新 · NCT05118789A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Oncology Hematology Associates, Springfield
- Washington University School of Medicine, St Louis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07218380A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Saint Luke's Cancer Institute, Kansas City
- Oncology Hematology Associates, Springfield
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07174336A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Washington University, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07114601SLV-154 Treatment of Advanced Cancers
- Washington University, St Louis
被験者募集中第1相
12歳以上 · 全性別 · 2026/09/22更新 · NCT06771219A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- University of Missouri Hospital, Columbia
- HCA Midwest Kansas City, MidAmerica Division, Inc., Kansas City
- Cox Medical Center North, Springfield
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213804Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Washington University, St Louis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT05267626A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
- Siteman Cancer Center (Washington University School of Medicine), St Louis
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/18更新 · NCT07450859Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Siteman Cancer Center - St. Peters, City of Saint Peters
- Siteman Cancer Center - West County, Creve Coeur
- Siteman Cancer Center - North County, Florissant
- 他4件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07227415A Study of KK2269 in Adult Participants With Solid Tumors
- Washington University, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06266299A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- Washington University School of Medicine, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06440005A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Oncology Hematology Associates, Springfield
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- Siteman Cancer Center at Washington University, St Louis
被験者募集中第1相
36 Months – 22 Years · 全性別 · 2026/09/04更新 · NCT03911388Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- Washington University School of Medicine, St Louis
- 他2件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/04更新 · NCT06311214A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- Washington University, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/28更新 · NCT07029399FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
- Washington University in St. Louis, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/20更新 · NCT05614739FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Washington University School of Medicine, St Louis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT05919264IDOV-Immune for Advanced Solid Tumors
- Washington University School of Medicine, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/05更新 · NCT06910657Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
- University of Kansas Cancer Center - North, Kansas City
- University of Kansas Cancer Center - Lee's Summit, Lee's Summit
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/31更新 · NCT05691491A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Washington University, St Louis
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/30更新 · NCT04657068Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #110, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/23更新 · NCT06545942Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
- Investigative Site #110, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/23更新 · NCT06974110Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
- Washington University, St Louis
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/07/14更新 · NCT05533697Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer
- Washington University School of Medicine, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/13更新 · NCT07137416A Study of PYX-201 in Advanced Solid Tumors
- Washington University School of Medicine, St Louis
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/30更新 · NCT05720117LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
- Luminis Health Radiation Oncology - Anne Arundel Health System, Annapolis
- University of Kansas Cancer Center - North, Kansas City
- University of Kansas Cancer Center - Lee's Summit, Lee's Summit
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/06/25更新 · NCT06216301ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。